KARACHI: Citi Pharma in its initial public offering (IPO) has raised Rs2.32 billion, making it the second pharmaceutical IPO in 23 years and the single largest of 2021 so far, a statement said on Wednesday.
The book-building process of Citi Pharma’s Initial Public Offer (IPO) has concluded with an oversubscription of two times, according to Topline Securities, advisor and book runner of the issue.
“The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs32/share, 14.3 percent higher than the floor price of Rs28,” the leading API ( active pharmaceutical ingredients) manufacturer of the country said in its statement.
Several brokerages had had issued almost unanimous calls to ‘subscribe,’ which resulted in investor demand amounting to Rs4 billion against the IPO’s book-building size of Rs2 billion. Investors who bid at Rs32 will get approximately 10 percent of their bid quantity.
“The response to the book building was far better than our expectations” said Mohammed Sohail of Topline Securities.
In the last IPO (Organic Meat) managed by Topline, investors had made a gain of close to 90 percent in a year, Sohail said.
The headquarters of the Sui Southern Gas Company . — APP FileKARACHI: Sui Southern Gas Company has launched a fresh...
The logo of the ExpoMed Eurasia. — CA MI websiteKARACHI: Pakistan is participating in ExpoMed Eurasia, a leading...
Gold bars are seen in this undated file photo. — AFP/FileKARACHI: Gold prices increased by Rs500 per tola on...
FFBL Head Office building can be seen in Islamabad. — FFBL WebsiteKARACHI: Fauji Fertilizer Bin Qasim Limited has...
Representational file of an BMW car. — AFP FileLAHORE: Small improvements in economic credentials of the country are...
A fuel station worker filling petrol in vehicle at a fuel station in Karachi on Tuesday, April 16, 2024KARACHI: After...